Literature DB >> 18180568

[An evaluation of eight cases of intraosseous lipoma].

Yilmaz Sahin1, Nevzat Dabak, M Bekir Selçuk, Y Sancar Bariş.   

Abstract

OBJECTIVES: We retrospectively evaluated patients with intraosseous lipoma.
METHODS: The study included eight patients (5 males, 3 females; mean age 39 years; range 23 to 60 years) who were treated between 1997 and 2005 for intraosseous lipoma. Localizations of the lipomas were the calcaneus in six patients, proximal humerus in one patient, and proximal femur in one patient. The presenting complaints were heel pain in patients with calcaneal involvement, and shoulder pain associated with proximal humeral involvement. In one patient, detection of intraosseous lipoma in the left proximal femur was incidental during examination for right hip pain. According to the Milgram classification, five of the intraosseous lipomas were stage 1, while two calcaneal lesions and one femoral lesion were stage 2. Treatment consisted of excisional biopsy, curettage, and allografting under regional or general anesthesia. The diagnosis was confirmed histopathologically in all cases. The mean follow-up period was 28 months (range 9 to 110 months).
RESULTS: Complaints of heel pain and shoulder pain resolved within four and five months, respectively. No infection or skin necrosis occurred at the wound site. No neurovascular complications developed during or after surgery. Radiological consolidation of the implanted bone allografts were complete by a mean of three months (range 2 to 4 months). No pathological fractures or recurrences were encountered.
CONCLUSION: Treatment of intraosseous lipomas with curettage and grafting is effective in relieving pain and preventing possible pathological fractures.

Entities:  

Mesh:

Year:  2007        PMID: 18180568

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  1 in total

1.  Intraosseous Angiolipoma of the Rib.

Authors:  Ali Celik; Celal Bugra Sezen; Onur Ertunc; Abdullah Irfan Tastepe
Journal:  Indian J Surg       Date:  2014-07-22       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.